Three-Year Safety and Effectiveness of Fixed-Dose Losartan/Hydrochlorothiazide Combination Therapy in Japanese Patients with Hypertension Under Clinical Setting (PALM-1 Extension Study)

By Kita Toshihiro   Yokota Naoto   Ichiki Yoshinari   Ayabe Takao   Etoh Takuma   Tamaki Noboru   Kato Johji   Eto Tanenao   Kitamura Kazuo  

Clinical and Experimental Hypertension, Vol. 34, Iss. 7, 2012-11 ,pp. : 498-503

Informa Healthcare

Access to resources Recommend Favorite

The efficacy and safety of irbesartan in primary hypertension even if a dose is missed: Results from the NO PROBLEM Study

By Kabakci Giray   Kaya Baris Ergun   Tulumen Erol   Kocabas Ugur   Abali Gulcan   Deveci Onur   Aytemir Kudret   Tokgozoglu Lale   Ozkutlu Hilmi  

Blood Pressure, Vol. 19, Iss. 1, 2010-02 ,pp. : 5-9

Informa Healthcare

Access to resources Recommend Favorite

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman

By  

Medical Principles and Practice, Vol. 22, Iss. 3, 2012-12 ,pp. : 265-269

Karger

Access to resources Recommend Favorite

Nebivolol/Hydrochlorothiazide: A New Fixed-Dose Combination for Effective Simplified Antihypertensive Therapy

By Malacco Ettore  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 2, 2008-01 ,pp. : 75-84

Adis International

Access to resources Recommend Favorite

Comparison of the Efficacy and Safety of Irbesartan and Olmesartan in Patients With Hypertension (EARTH Study)

By Morii Joji   Miura Shin-ichiro   Shiga Yuhei   Sugihara Makoto   Arimura Tadaaki   Sako Hideto   Zhang Bo   Uehara Yoshinari   Saku Keijiro  

Clinical and Experimental Hypertension, Vol. 34, Iss. 5, 2012-08 ,pp. : 342-349

Informa Healthcare

Access to resources Recommend Favorite